Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Ixel hydrochloride

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,128Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Macleods Pharms’ Generics Milnacipran HCl Receives Approval in US
    Macleods Pharms’ Generics Milnacipran HCl Receives Approval in US

    12 Feb 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210944

    FDA
    12 Feb 2026
    Share Share
    Hetero Lab`s Generics Milnacipran HCl Receives Approval in US
    Hetero Lab`s Generics Milnacipran HCl Receives Approval in US

    03 Oct 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205147

    FDA
    03 Oct 2024
    Share Share
    Macleods Pharm's Generic Milnacipran Hydrochloride Receives Approval in the U.S.
    Macleods Pharm's Generic Milnacipran Hydrochloride Receives Approval in the U.S.

    05 Jan 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210944

    FDA
    05 Jan 2022
    Share Share
    Macleods Pharms's Generic Milnacipran Hydrochloride Receives Approval in US
    Macleods Pharms's Generic Milnacipran Hydrochloride Receives Approval in US

    13 Nov 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210944

    FDA
    13 Nov 2018
    Share Share
    Strides Shasun gets US FDA nod for ibuprofen; tentative nod for milnacipran HCl
    Strides Shasun gets US FDA nod for ibuprofen; tentative nod for milnacipran HCl

    04 Jul 2018

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=109812&sid=2

    PHARMABIZ
    04 Jul 2018
    Share Share
    Drug Formulation, Solubility & Bioavailability Summit
    Drug Formulation, Solubility & Bioavailability Summit

    25 Apr 2016

    // PHARMA-EXCIPIENTS

    http://www.pharma-excipients.ch/2016/04/25/drug-formulation-solubility-bioavailability-summit/

    PHARMA-EXCIPIENTS
    25 Apr 2016
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.